NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer

MLA

Eoin Dinneen, et al. “NeuroSAFE PROOF: Study Protocol for a Single-Blinded, IDEAL Stage 3, Multi-Centre, Randomised Controlled Trial of NeuroSAFE Robotic-Assisted Radical Prostatectomy versus Standard Robotic-Assisted Radical Prostatectomy in Men with Localized Prostate Cancer.” Trials, vol. 23, no. 1, July 2022, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13063-022-06421-7.

APA

Eoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, Rosie Clow, Aiman Haider, Clare Allen, Daniel Heffernan-Ho, Alex Freeman, Tim Briggs, Senthil Nathan, Susan Mallett, Chris Brew-Graves, Nicola Muirhead, Norman R. Williams, Elena Pizzo, Raj Persad, Jon Aning, Lyndsey Johnson, Jon Oxley, … Greg Shaw. (2022). NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer. Trials, 23(1), 1–16. https://doi.org/10.1186/s13063-022-06421-7

Chicago

Eoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, Rosie Clow, Aiman Haider, Clare Allen, Daniel Heffernan-Ho, et al. 2022. “NeuroSAFE PROOF: Study Protocol for a Single-Blinded, IDEAL Stage 3, Multi-Centre, Randomised Controlled Trial of NeuroSAFE Robotic-Assisted Radical Prostatectomy versus Standard Robotic-Assisted Radical Prostatectomy in Men with Localized Prostate Cancer.” Trials 23 (1): 1–16. doi:10.1186/s13063-022-06421-7.